Список литературы

1. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012. - N 4. - сс 3 - 10.

2. Алиев М.Д. Злокачественные опухоли костей Саркомы костей, мягких тканей и опухоли кожи. 2010. - N 2. - сс 3 - 8

3. Алиев М.Д. Эндопротезирование как основа онкоортопедии Саркомы костей, мягких тканей и опухоли кожи. 2010. - N 4. - сс 7 - 12

4. А.А. Курильчик, А.Л. Зубарев, Г.Т. Кудрявцева, А.Л. Стародубцев. Интраоперационная лучевая терапия (ИОЛТ) в комбинированном лечении остеосаркомы. Саркомы костей, мягких тканей и опухоли кожи. 2010. - N 3. - сс 30 - 33

5. Тепляков В.В., Карпенко В.Ю., Бухаров А.В., Державин В.А., Урлова А.Н., Рубцова Н.А. Результаты хирургического лечения пациентов с метастазами в длинные трубчатые кости. Саркомы костей, мягких тканей и опухоли кожи. 2010. - N 3. - сс 10 - 15

6. Malawer M.M., Helman L.J., O'Sullivan B. Sarcomas of bone. / DeVita, Hellman, and Rosenberg"s Cancer: Principles & Practice of Oncology. - 2008. - 8th ed. - vol. 2. - pp. 1794 - 1833

7. Kalra S1, Grimer RJ, Spooner D. et al. Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br. 2007 Jun; 89(6): 808 - 13.

8. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing"s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694 - 701.

9. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112 - 128

10. Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group. J Clin Oncol 2012 Nov 20; 30(33): 4148 - 54

11. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911 - 917.

12. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensi ed chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112 - 128

13. Fiorenza F, Abudu A, Grimer RJ, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br 2002; 84: 93 - 99

14. Marulanda GA, Henderson ER, Johnson DA, et al. Orthopedic surgery options for the treatment of primary osteosarcoma. Cancer Control 2008; 15: 13 - 20.

15. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002; 84: 88 - 92.

16. Kager L1, Zoubek A, Potschger U. et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003 May 15; 21(10): 2011 - 8.

17. Gogna A1, Peh WC, Munk PL. Image-guided musculoskeletal biopsy. Radiol Clin North Am. 2008 May; 46(3): 455 - 73

18. Gupta AA1, Pappo A, Saunders N. et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010 Jul 1; 116(13): 3189 - 94

19. Bacci G1, Forni C, Longhi A, Ferrari S. et al. Long-term outcome for patients with non-metastatic Ewing"s sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004 Jan; 40(1): 73 - 83.

20. Bielack SS1, Kempf-Bielack B, Delling G. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002 Feb 1; 20(3): 776 - 90.

21. Bernthal NM1, Federman N, Eilber FR. et al. Long-term results (> 25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer. 2012 Dec 1; 118(23): 5888 - 93.

22. Smeland S1, Bruland OS, Hjorth L. et al. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years. Acta Orthop. 2011 Apr; 82(2): 211 - 6